Synaptogenix Inc (SNPX)

[doingmybest]

Xenalives, I cannot say I have been close to NTRP, but, I have contacted them multiple times and now they have an IR person as before it was their CFO. In recent months they have shifted from a staff of a few to a much more robust organization with new needed skills and focus. They are not complete but now they have sufficient cash to build out a little. They have deep technical needs due to their supply chain and dosage form. If their P2b pans out obviously they would have more than enough cash to invest with, and, they would probably have time constraints to line up their supply chain with commercial regulation and volume requirements. But, they are all exciting challenges to have as long as they are manageable with time, money and expertise. The key obviously is P2b results, then on to all the details of commercialization and P3 confirmation. I would have to believe they would seek a BT designation from FDA and the possibility of AA and PR,... They have stated they will read out top line in April but I just saw where they were not fully enrolled, so, I have to think April is in jeaopardy and maybe a month or two slippage may occur if the number I saw of 119 enrolled was accurate.